Department of Disease Glycomics, The institute of Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibaraki, 567-0041, Japan.
Glycobiology. 2010 Jan;20(4):485-97. doi: 10.1093/glycob/cwp200. Epub 2009 Dec 16.
N-Acetylglucosaminyltransferase-IV (GnT-IV) has two isoenzymes, GnT-IVa and GnT-IVb, which initiate the GlcNAcbeta1-4 branch synthesis on the Manalpha1-3 arm of the N-glycan core thereby increasing N-glycan branch complexity and conferring endogenous lectin binding epitopes. To elucidate the physiological significance of GnT-IV, we engineered and characterized GnT-IVb-deficient mice and further generated GnT-IVa/-IVb double deficient mice. In wild-type mice, GnT-IVa expression is restricted to gastrointestinal tissues, whereas GnT-IVb is broadly expressed among organs. GnT-IVb deficiency induced aberrant GnT-IVa expression corresponding to the GnT-IVb distribution pattern that might be attributed to increased Ets-1, which conceivably activates the Mgat4a promoter, and thereafter preserved apparent GnT-IV activity. The compensative GnT-IVa expression might contribute to amelioration of the GnT-IVb-deficient phenotype. GnT-IVb deficiency showed mild phenotypic alterations in hematopoietic cell populations and hemostasis. GnT-IVa/-IVb double deficiency completely abolished GnT-IV activity that resulted in the disappearance of the GlcNAcbeta1-4 branch on the Manalpha1-3 arm that was confirmed by MALDI-TOF MS and GC-MS linkage analyses. Comprehensive glycomic analyses revealed that the abundance of terminal moieties was preserved in GnT-IVa/-IVb double deficiency that was due to the elevated expression of glycosyltransferases regarding synthesis of terminal moieties. Thereby, this may maintain the expression of glycan ligands for endogenous lectins and prevent cellular dysfunctions. The fact that the phenotype of GnT-IVa/-IVb double deficiency largely overlapped that of GnT-IVa single deficiency can be attributed to the induced glycomic compensation. This is the first report that mammalian organs have highly organized glycomic compensation systems to preserve N-glycan branch complexity.
N-乙酰氨基葡萄糖基转移酶-IV(GnT-IV)有两种同工酶,GnT-IVa 和 GnT-IVb,它们在 N-糖链核心的 Manα1-3 臂上启动 GlcNAcbeta1-4 分支合成,从而增加 N-糖链分支的复杂性,并赋予内源性凝集素结合表位。为了阐明 GnT-IV 的生理意义,我们构建并鉴定了 GnT-IVb 缺陷型小鼠,并进一步生成 GnT-IVa/-IVb 双缺陷型小鼠。在野生型小鼠中,GnT-IVa 表达仅限于胃肠道组织,而 GnT-IVb 在各种器官中广泛表达。GnT-IVb 缺陷诱导 GnT-IVa 表达异常,与 GnT-IVb 的分布模式相对应,这可能归因于 Ets-1 的增加,Ets-1 可能激活 Mgat4a 启动子,从而保持明显的 GnT-IV 活性。代偿性 GnT-IVa 表达可能有助于改善 GnT-IVb 缺陷型表型。GnT-IVb 缺陷在造血细胞群和止血方面表现出轻微的表型改变。GnT-IVa/-IVb 双缺陷完全消除了 GnT-IV 活性,导致 Manα1-3 臂上的 GlcNAcbeta1-4 分支消失,这通过 MALDI-TOF MS 和 GC-MS 键合分析得到证实。全面的糖组学分析表明,GnT-IVa/-IVb 双缺陷型中末端部分的丰度得以保留,这是由于与末端部分合成有关的糖基转移酶的表达升高所致。因此,这可能维持内源性凝集素糖配体的表达并防止细胞功能障碍。GnT-IVa/-IVb 双缺陷型的表型在很大程度上与 GnT-IVa 单缺陷型重叠,这归因于诱导的糖组学补偿。这是哺乳动物器官具有高度组织化的糖组学补偿系统以维持 N-糖链分支复杂性的首个报道。